CVS Long based on RSI DivergenceNYSE:CVS
Long, based on 1D RSI Divergence.
Heavy cost of Aetna acquisition weighed heavily the past year, despite fairly strong earnings.
Although a judge is re-verifying the federally greenlighted merger, posing downside risk, the merger will likely continue through.
Stop loss at 51.50
CVS trade ideas
CVS: A Long Term Ending Diagonal followed by a leading Diagonal were correctly counted. What was not expected was the 5th wave of the Leading Diagonal extending past the Top Rail. Nonetheless, expect a small drop to retest the top rail breakout and if it passes, wave (III) should take CVS to new heights.
$CVS The Winner of Retail PharmacyAscending triangle in the making
RSI and MACD are sells right now
Look for a drop in the next few days to 77 within the ascending triangle range, then up and out from there
Fundamentally, CVS is one of my favorite companies. It will transform the healthcare space (overview below)
CVS officially closed on its Aetna deal over the last few weeks.
Most are unaware of the implications of such a deal. CVS now owns a health insurer, PBM, thousands of pharmacies, and quite possibly the most important piece that most are unaware of, their minute clinics located within stores.
When you need to see a health care professional, you can now walk into a CVS, get diagnosed, pick up your medication, and be billed through the same plan. Because of this one stop shop, CVS as a whole can begin to offer health packages for these conveniences at a much better rate than competitors since their costs will drop tremendously. They can pay their health care professionals a salary, rather than a diagnosis code that is much more expensive and variable to say the least. PBMs typically take a large cut, but CVS already owns Caremark .They own each piece of the healthcare chain that used to take a cut of profits. If CVS can get the internal workflow together, CVS will run the next generation healthcare space.